CODE Trademark

Trademark Overview

On Thursday, March 14, 2019, a trademark application was filed for CODE with the United States Patent and Trademark Office. The USPTO has given the CODE trademark a serial number of 88339512. The federal status of this trademark filing is ABANDONED - AFTER EX PARTE APPEAL as of Thursday, May 28, 2020. This trademark is owned by Baker Tilly Virchow Krause, LLP. The CODE trademark is filed in the Advertising, Business and Retail Services category with the following description:

Consultancy and advisory services in the field of business strategy, namely, strategies for optimizing clinical trial operations; business assessment services, namely, providing analysis of clinical trial business practices in order to improve people, process, and technology strategies; business consultation regarding launching of new drug, pharmaceutical, and medical device products, excluding advertising, marketing, and promotion of such products
code

General Information

Serial Number88339512
Word MarkCODE
Filing DateThursday, March 14, 2019
Status603 - ABANDONED - AFTER EX PARTE APPEAL
Status DateThursday, May 28, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesConsultancy and advisory services in the field of business strategy, namely, strategies for optimizing clinical trial operations; business assessment services, namely, providing analysis of clinical trial business practices in order to improve people, process, and technology strategies; business consultation regarding launching of new drug, pharmaceutical, and medical device products, excluding advertising, marketing, and promotion of such products

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, April 3, 2019
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBaker Tilly Virchow Krause, LLP
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressMadison, WI 53718

Trademark Events

Event DateEvent Description
Friday, June 5, 2020ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
Thursday, May 28, 2020ABANDONMENT - AFTER EX PARTE APPEAL
Thursday, May 28, 2020EXPARTE APPEAL TERMINATED
Tuesday, April 14, 2020EXPARTE APPEAL DSMSED - FAILURE TO FILE BRIEF
Thursday, January 30, 2020NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Thursday, January 30, 2020ACTION DENYING REQ FOR RECON E-MAILED
Thursday, January 30, 2020ACTION CONTINUING FINAL - COMPLETED
Thursday, January 9, 2020EX PARTE APPEAL-INSTITUTED
Thursday, January 9, 2020JURISDICTION RESTORED TO EXAMINING ATTORNEY
Thursday, January 9, 2020EXPARTE APPEAL RECEIVED AT TTAB
Sunday, December 29, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, December 29, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 5, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 5, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 5, 2019TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, July 12, 2019NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, July 12, 2019FINAL REFUSAL E-MAILED
Friday, July 12, 2019FINAL REFUSAL WRITTEN
Tuesday, June 25, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 25, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 3, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, June 2, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, June 2, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, April 20, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, April 20, 2019NON-FINAL ACTION E-MAILED
Saturday, April 20, 2019NON-FINAL ACTION WRITTEN
Monday, April 15, 2019ASSIGNED TO EXAMINER
Wednesday, April 3, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, March 18, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

code business strategies trial products namely clinical services drug pharmaceutical launching